ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification
Fig 5
Enrichment analysis of ADAMTSL2 in CRC (GSEA).
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Enrichment analysis of ADAMTSL2 in CRC (GSEA).